Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neovascularization via endothelial progenitor cell activity refers to the process by which endothelial progenitor cells (EPCs) contribute to the formation of new blood vessels. This process involves the mobilization of EPCs from the bone marrow into the circulation, their recruitment to sites of neovascularization, and their differentiation into mature endothelial cells. EPCs also release paracrine factors that support angiogenesis. This process is crucial in various physiological and pathological conditions, including wound healing, ischemic diseases, and cancer progression.
Inhibition or enhancement of angiogenic factors (e.g., VEGF) Modulation of EPC mobilization and differentiation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neovascularization via Endothelial Progenitor Cell Activity.